Last news
embecta to Participate in Upcoming Investor Conferences

embecta to Participate in Upcoming Investor Conferences

PARSIPPANY, N.J., Feb. 08, 2023 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), one of the largest pure-play diabetes care companies in the......

Raleigh Sullivan Joins Pfluger as Houston Office Managing

Raleigh Sullivan Joins Pfluger as Houston Office Managing

Austin, TX, Feb. 08, 2023 (GLOBE NEWSWIRE) -- Raleigh Sullivan has joined Pfluger Architects as Managing Principal of the firm’s Houston office. A......

Travere Therapeutics to Present at Upcoming Investor

Travere Therapeutics to Present at Upcoming Investor

SAN DIEGO, Feb. 08, 2023 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that Company management will participate in the......

Plains All American Reports Fourth-Quarter and Full-Year

Plains All American Reports Fourth-Quarter and Full-Year

HOUSTON, Feb. 08, 2023 (GLOBE NEWSWIRE) -- Plains All American Pipeline, L.P. (Nasdaq: PAA) and Plains GP Holdings (Nasdaq: PAGP) today reported......

Runway Growth Finance Corp. Announces Date for Fourth

Runway Growth Finance Corp. Announces Date for Fourth

WOODSIDE, Calif., Feb. 08, 2023 (GLOBE NEWSWIRE) -- Runway Growth Finance Corp. (Nasdaq: RWAY) (“Runway Growth”), a leading provider of flexible capital......

Palomar Holdings, Inc. Announces Fourth Quarter and Full

Palomar Holdings, Inc. Announces Fourth Quarter and Full

LA JOLLA, Calif., Feb. 08, 2023 (GLOBE NEWSWIRE) -- Palomar Holdings, Inc. (NASDAQ: PLMR) (the “Company”) today announced that it will release its fourth......

Global-e to Announce Financial Results for the Fourth

Global-e to Announce Financial Results for the Fourth

PETAH-TIKVA, Israel, Feb. 08, 2023 (GLOBE NEWSWIRE) -- Global-e Online Ltd. (Nasdaq: GLBE) the global leader of Direct-To-Consumer cross border......

DICE Therapeutics to Participate at Upcoming Investor

DICE Therapeutics to Participate at Upcoming Investor

SOUTH SAN FRANCISCO, Calif., Feb. 08, 2023 (GLOBE NEWSWIRE) -- DICE Therapeutics, Inc. (Nasdaq: DICE), a biopharmaceutical company leveraging its......

1 ... 883 884 885 886 887 888 889 890 891 ... 982
menu
menu